The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer

PURPOSE: We previously demonstrated that CD44v9 and Ki-67 played an important role in predicting poor prognosis of early gastric cancer (EGC). However, little is known about combined use of both biomarkers as prognostic biomarker. The present study was performed to investigate the significance of CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Se-Il, Ko, Gyung Hyuck, Lee, Won Sup, Lee, Jeong-Hee, Jeong, Sang-Ho, Lee, Young-Joon, Hong, Soon Chan, Ha, Woo Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790844/
https://www.ncbi.nlm.nih.gov/pubmed/30913874
http://dx.doi.org/10.4143/crt.2018.663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790844/
https://www.ncbi.nlm.nih.gov/pubmed/30913874
http://dx.doi.org/10.4143/crt.2018.663

Ejemplares similares